NCT01832168已完成不适用
A Prospective Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy (RALP)- Effect on Nerve Protection.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 2
- 主要终点
- The proportion of patients achieving return to baseline Sexual Health Inventory for Men (SHIM) score in the AmnioFix group versus the Control group.
研究概览
简要总结
The purpose of this study is to determine whether the AmnioFix dehydrated human amniotic membrane is effective in protecting nerves in men receiving robotic assisted laparoscopic prostatectomies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 70 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Clinically localized prostate cancer with Gleason score 6 or 7
- •SHIM Score greater than or equal to 16 in the absence of medication
- •Feasibility to perform unilateral or bilateral nerve sparing RALP
排除标准
- •Clinically locally advanced cancer and/or with Gleason score 8 or
- •Difficulty performing nerve sparing RALP.
- •Prior surgery at the site.
- •Site exhibits clinical signs and symptoms of infection.
- •SHIM score at screening <
- •Current use of anticoagulant medication including Coumadin, Plavix, etc.
- •Has had "salvage prostatectomy" - patients who failed prior therapies including external radiation therapy, cryotherapy, etc.
- •Has prior radiation therapy treatment at the site.
- •Prior hormonal therapy such as Lupron or oral anti-androgens.
- •Non-mobile, i.e. not ambulatory or bed ridden.
- •The presence of comorbidities that can be confused with or can exacerbate the condition including:
- •advanced atherosclerotic vascular disease
- •Patients with a history of more than two weeks treatment with immuno-suppressants (including systemic corticosteroids), cytotoxic chemotherapy within one month prior to initial screening, or who receive such medications during the screening period, or who are anticipated to require such medications during the course of the study.
- •Patients on any investigational drug(s) or therapeutic device(s) within 30 days preceding screening.
- •Unable to comply with penile rehabilitation.
- •Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV.
- •Patients who are unable to understand the aims and objectives of the trial.
- •Presence of any condition(s) which seriously compromises the subject's ability to complete this study, or has a known history of poor adherence with medical treatment.
- •Currently taking medications which could affect graft incorporation (supervising physician's discretion).
- •Allergic to gentamicin and/or streptomycin.
- •Damage to neurovascular bundles during surgery.
结局指标
主要结局
The proportion of patients achieving return to baseline Sexual Health Inventory for Men (SHIM) score in the AmnioFix group versus the Control group.
时间窗: 4 weeks
次要结局
- Time to return of erectile function.(Up to 6 months)
- Pain scores.(10 days, 4 weeks, 3 months, and 6 months)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot UlcersUlcer FootFoot UlcerDiabetic FootDiabetic Foot UlcerNCT06550596Axolotl Biologix100
已完成
不适用
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar FasciitisPlantar FasciitisNCT01659827MiMedx Group, Inc.45
终止
不适用
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly PopulationVenous Leg UlcerNCT06544564BioLab Holdings30
进行中（未招募）
2 期
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical ProstatectomyProstate CancerErectile Dysfunction Following Radical ProstatectomyNCT05842057University of Miami118
已完成
不适用
Use of dHACM in the Treatment of Venous Leg UlcersLeg UlcerNCT02011503MiMedx Group, Inc.128